Skip to Content

West-ward 3189 (Lithium Carbonate 300 mg)

Pill with imprint West-ward 3189 is Gray & Yellow, Capsule-shape and has been identified as Lithium Carbonate 300 mg. It is supplied by West-Ward Pharmaceutical Corporation.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; cyclothymic disorder; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for West-ward 3189

Lithium Carbonate

Imprint:
West-ward 3189
Strength:
300 mg
Color:
Gray & Yellow
Size:
20.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
West-Ward Pharmaceutical Corporation
Inactive Ingredients:
magnesium silicate
gelatin
titanium dioxide
butyl alcohol
propylene glycol
ferrosoferric oxide
FD&C Green No. 3
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
63739-0265 McKesson Packaging Services
43063-0196 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide